Syngene International
- Advice
- Hold
Syngene International Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Syngene International
Start SIPSyngene International Investment Rating
-
Master Rating:
-
Syngene Inter has an operating revenue of Rs. 2,956.60 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 19% is great, ROE of 12% is good. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around -0% and -0% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 59 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 61 indicates it belongs to a poor industry group of Medical-Research Eqp/Svc and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 787 | 768 | 645 | 759 |
| Operating Expenses Qtr Cr | 556 | 552 | 473 | 509 |
| Operating Profit Qtr Cr | 230 | 216 | 172 | 249 |
| Depreciation Qtr Cr | 95 | 90 | 86 | 80 |
| Interest Qtr Cr | 14 | 12 | 9 | 6 |
| Tax Qtr Cr | 30 | 28 | 19 | 31 |
| Net Profit Qtr Cr | 110 | 102 | 73 | 147 |
Syngene International Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 577.92
- 50 Day
- 579.2
- 100 Day
- 581.55
- 200 Day
- 582.23
- 20 Day
- 578.74
- 50 Day
- 579.44
- 100 Day
- 589.07
- 200 Day
- 580.23
Syngene International Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 583.17 |
| Second Resistance | 587.09 |
| Third Resistance | 590.17 |
| RSI | 51.11 |
| MFI | 49.01 |
| MACD Single Line | 0.67 |
| MACD | 0.6 |
| Support | |
|---|---|
| First Resistance | 576.17 |
| Second Resistance | 573.09 |
| Third Resistance | 569.17 |
Syngene International Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 455,922 | 24,437,419 | 53.6 |
| Week | 399,904 | 22,610,572 | 56.54 |
| 1 Month | 425,250 | 23,933,054 | 56.28 |
| 6 Month | 858,950 | 60,049,214 | 69.91 |
Syngene International Result Highlights
Syngene International Synopsis
NSE-Medical-Research Eqp/Svc
Syngene Internationa is involved in the business activities of Scientific research and development. Company’s Total Operating Revenue is Rs. 2601.40 Cr. and Equity Capital is Rs. 400.80 Cr. for the Year ended 31/03/2022. Syngene International Ltd. is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937.| Market Cap | 22,937 |
| Sales | 2,958 |
| Shares in Float | 14.05 |
| No of funds | 289 |
| Yield | 0.09 |
| Book Value | 7.05 |
| U/D Vol ratio | 1.1 |
| LTDebt / Equity | 16 |
| Alpha | -0.01 |
| Beta | 0.66 |
Syngene International
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 64.86% | 64.86% | 70.29% | |
| Mutual Funds | 5.01% | 4.78% | 2.79% | |
| Insurance Companies | 0.32% | 0.17% | ||
| Foreign Portfolio Investors | 16.87% | 16.79% | 14.12% | |
| Financial Institutions/ Banks | 0.01% | |||
| Individual Investors | 8.57% | 8.82% | 9.03% | |
| Others | 4.37% | 4.57% | 3.77% |
Syngene International Management
| Name | Designation |
|---|---|
| Ms. Kiran Mazumdar Shaw | Non Executive Chairman |
| Mr. Jonathan Hunt | Managing Director & CEO |
| Prof. Catherine Rosenberg | Non Executive Director |
| Ms. Vinita Bali | Lead Independent Director |
| Dr. Vijay Kuchroo | Independent Director |
| Dr. Carl Decicco | Independent Director |
| Ms. Sharmila Abhay Karve | Independent Director |
| Dr. Kush Parmar | Independent Director |
| Mr. Paul Blackburn | Independent Director |
Syngene International Forecast
Price Estimates
Syngene International FAQs
What is Share Price of Syngene International ?
Syngene International share price is ₹575 As on 24 March, 2023 | 15:35
What is the Market Cap of Syngene International ?
The Market Cap of Syngene International is ₹23090.5 Cr As on 24 March, 2023 | 15:35
What is the P/E ratio of Syngene International ?
The P/E ratio of Syngene International is 53.3 As on 24 March, 2023 | 15:35
What is the PB ratio of Syngene International ?
The PB ratio of Syngene International is 7 As on 24 March, 2023 | 15:35